INSIGHTS ON DRUG DEVELOPMENT

DRUG DEVELOPMENT SOLUTIONS

  • Waters has a complete portfolio of liquid chromatography and LC-MS solutions to provide you with accurate data to answer your lab's most pressing questions.

  • Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to inadequate insulin production or impaired insulin utilization, commonly known as insulin resistance.

  • Designed for today’s assays and tomorrow’s breakthroughs—flexible detection that evolves with your science.

    The SpectraMax® iD3s and iD5e Multi-Mode Microplate Readers deliver flexible, scalable solutions for absorbance, fluorescence, and luminescence assays—with advanced capabilities for evolving research needs. The iD3s reader offers a streamlined, affordable platform with a tunable monochromator and temperature control, while the iD5e reader adds enhanced detection modes including time-resolved fluorescence (TRF) and tunable fluorescence polarization (FP) and can be expanded to include TR-FRET, HTRF, BRET and western blot. Both readers support on board fluidics with optional dual injectors.

  • Re-engineer your drug's path into clinical development and accelerate time to Proof-of-Concept. Real-time data guides rapid formulation iterations, minimizing drug substance use and lowering program risk.

  • Sterility is key for high-risk applications such as injectables, parenteral formulations, ophthalmic and peritoneal dialysis solutions, and many more.